Sponsors (4)
The bill channels significant federal money and coordination to scale alternative-protein research, workforce training, and domestic supply chains—boosting jobs, innovation, and food‑security resilience—but at the cost of substantial taxpayer spending, potential diversion of resources from traditional agriculture, concentrated benefits for larger firms, and increased regulatory and safety challenges.
Researchers, U.S. agritech firms, and manufacturers gain substantial new federal R&D and commercialization funding and grant eligibility to develop scalable alternative proteins and biomanufacturing.
Students and workers get expanded training, scholarships, and workforce pathways into food biomanufacturing and related STEM fields, supporting job creation in biotech and bioprocessing.
Farmers and rural communities gain new market opportunities and potential value-added income by supplying feedstocks and participating in biomass-to-protein value chains, helping diversify local economies.
Taxpayers face substantial new federal spending or redirected funds across multiple programs (multi‑year authorizations and grant programs), which could crowd out other USDA or federal priorities.
Shifting research and grant priorities toward alternative proteins risks diverting funding and attention away from traditional agricultural programs and could economically harm livestock producers and dependent rural communities.
Large minimum grant sizes, commercial-scale funding emphases, and well‑resourced applicants increase the likelihood that benefits concentrate with larger firms and established institutions, excluding startups and smaller, community-scale innovators.
Based on analysis of 9 sections of legislative text.
Creates USDA centers, grants, and a national strategy to scale domestic alternative-protein biomanufacturing and workforce development, authorizing about $100M/year for FY2026–2030 (authorization only).
Introduced December 17, 2025 by Adam Schiff · Last progress December 17, 2025
Establishes multiple USDA-led programs, grants, and a national strategy to expand domestic production, research, and workforce training for alternative and diversified protein sources using bioprocessing, biomanufacturing, and conversion of under-utilized biomass. The bill creates Centers of Excellence, changes research priorities, funds ARS and competitive grant programs for commercial-scale facilities and workforce development, and requires a whole-of-government protein security strategy; it authorizes about $100 million per year for FY2026–2030 in program funding but does not itself appropriate those funds.